Get started
Author

Mariangela Lecciso

Observed names: Lecciso M, Lecciso, Mariangela Stefania, M. Lecciso
OpenAlex ID: A5073016552
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
2017 · Sara Trabanelli, Mathieu F. Chevalier, et al. · Nature Communications · 235
PDF
Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients
2016 · Antonio Curti, Loredana Ruggeri, et al. · Clinical Cancer Research · 142
PDF
ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
2017 · Mariangela Lecciso, Darina Ocadlikova, et al. · Frontiers in Immunology · 100
CD127+ innate lymphoid cells are dysregulated in treatment naive acute myeloid leukemia patients at diagnosis
2015 · S. Trabanelli, A. Curti, et al. · Haematologica · 89
PDF
The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment
2014 · Alessandro Isidori, Valentina Salvestrini, et al. · Expert Review of Hematology · 85
The SOCS3-Independent Expression of IDO2 Supports the Homeostatic Generation of T Regulatory Cells by Human Dendritic Cells
2014 · Sara Trabanelli, Darina Očadlíková, et al. · The Journal of Immunology · 70
PGE2-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit anIn VitroAntileukemic Immune Response
2015 · Sara Trabanelli, Mariangela Lecciso, et al. · Journal of Immunology Research · 54
PDF
Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia
2019 · Darina Ocadlikova, Mariangela Lecciso, et al. · Frontiers in Oncology · 37
PDF
Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade
2021 · Darina Ocadlikova, Mariangela Lecciso, et al. · Frontiers in Immunology · 32
The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia
2017 · Sarah Parisi, Mariangela Lecciso, et al. · Frontiers in Immunology · 24
PDF
Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease
2018 · Monica Moresco, Mariangela Lecciso, et al. · Sleep Medicine · 19
Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach
2018 · Alessandro Isidori, Federica Loscocco, et al. · Cancers · 13
PDF
An evaluation of genotoxicity in human neuronal-type cells subjected to oxidative stress under an extremely low frequency pulsed magnetic field
2014 · Gianfranco Giorgi, Mariangela Lecciso, et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 12
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1
2015 · Darina Očadlíková, Sara Trabanelli, et al. · Experimental Hematology · 5
Flow cytometry T cell profiling in a recent-onset narcoleptic type 1 child: a case report
2019 · Monica Moresco, Mariangela Lecciso, et al. · Sleep Medicine · 4
Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells
2014 · Antonio Curti, Loredana Ruggeri, et al. · Blood · 3
Quantitative Assessment of Indoleamine 2,3-Dioxygenase (IDO) Expression at Diagnosis Predicts Clinical Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation
2018 · Sarah Parisi, Simone Ragaini, et al. · Blood · 2
Renewing the immunological approach to AML treatment: from novel pathways to innovative therapies
2016 · Alessandro Isidori, Federica Loscocco, et al. · Cancer Research Frontiers · 2
The Induction of Inhibitory Pathways in Dendritic Cells May Hamper the Efficient Activation of Anti-Leukemia T Cells within Chemotherapy-Induced Immunogenic Cell Death
2015 · Darina Ocadlikova, Mariangela Lecciso, et al. · Blood · 1
Supplementary Tables S1 and S2 from Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients
2023 · Antonio Curti, Loredana Ruggeri, et al.
supplemental figure legend from Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients
2023 · Antonio Curti, Loredana Ruggeri, et al.
Figure S1 from Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients
2023 · Antonio Curti, Loredana Ruggeri, et al.
Figure S4 from Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients
2023 · Antonio Curti, Loredana Ruggeri, et al.
Figure S2 from Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients
2023 · Antonio Curti, Loredana Ruggeri, et al.
Figure S3 from Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients
2023 · Antonio Curti, Loredana Ruggeri, et al.
Works count: 38
Citation count: 929
H-index: 12
I10-index: 13
Year
Topic
Type